In short. The specialties that take part in a multidisciplinary review, the question each one answers, and why some of them are present mainly to say no.
Key points
- Some specialties take part mainly in order to say no.
- Anaesthesia may rule out a duration.
- Oncology may require a delay.
A joint review is not a large meeting for its own sake. Each specialty takes part because it owns a question that nobody else can answer, and the value of the meeting depends on those questions being genuinely different. The exact membership depends on the case, but the same roles recur.
Surgery
The operating surgeon owns the technical question: what can be removed, what can be reconstructed, with what tissue, in what order, and what the result is likely to look like. In reconstructive work this is usually plastic surgery, and the surgeon is normally the person who presents the case.
Dermatology
Where the problem begins in the skin, dermatology owns the diagnosis and the medical treatment around it. That includes confirming what a lesion actually is, managing skin disease that affects healing, and judging whether a condition should be treated medically before or after any operation.
Pathology
Pathology answers what the tissue is. That determines whether margins matter, whether further treatment is likely, and how much tissue needs to be removed. A plan built before the pathology is known is a provisional plan, and it should be described as one.
Imaging
Radiology answers what lies beneath and how far the problem extends. It defines the anatomy the surgeon will meet, and it is often the specialty that identifies an unexpected finding which changes the approach.
Anaesthesia
Anaesthesia owns the question of whether the patient can safely tolerate the proposed procedure, and how long the operation can reasonably run. This is frequently the specialty that limits a plan rather than expands it.
The role nobody expects
Some specialties take part mainly in order to say no. Anaesthesia may rule out a duration. Oncology may require a delay. Nursing may report that a patient is not ready. A team that only ever agrees is not reviewing anything.
Oncology and other specialties
Where cancer is involved, oncology contributes the timing of any further treatment and the constraints that places on reconstruction. Other specialties are added as the case requires — endocrinology for poorly controlled diabetes, haematology for a clotting problem, or a physician for the patient's general condition.
A review has failed if
- Every specialty agrees without anyone testing the plan against a real objection.
- A specialty that owns a genuine risk was never invited, so that risk was never weighed.
- The decision is recorded without the reasoning, so it cannot be examined later.
Nursing and care coordination
Nursing reports what the patient's day-to-day condition actually is, what aftercare will demand, and whether the plan is realistic for that person at home. Care coordination keeps the record, tracks what was decided, and makes sure the plan that leaves the room is the plan the patient hears.
Frequently asked questions
Why is each specialty at an MDT meeting?
Because it owns a question that nobody else can answer, and the value of the meeting depends on those questions being genuinely different. Membership depends on the case, but the roles recur: surgery owns what can be removed and reconstructed, pathology answers what the tissue is, and radiology defines the anatomy.
Is there a specialty whose role is mainly to say no?
Yes. Anaesthesia may rule out a duration, oncology may require a delay, and nursing may report that a patient is not ready. Those contributions limit a plan rather than expand it, and a team that only ever agrees is not reviewing anything.
What do nursing and care coordination contribute?
Nursing reports what the patient’s day-to-day condition actually is, what aftercare will demand, and whether the plan is realistic for that person at home. Care coordination keeps the record, tracks what was decided, and makes sure the plan that leaves the room is the plan the patient hears.
Risks & Limitations
- An MDT reduces the chance of a plan that ignores something important, but it cannot remove risk.
- Consensus is not certainty. A group of specialists can share the same blind spot, and agreement is not evidence.
- A joint plan can still require revision if the pathology differs, tissue heals badly, or circumstances change.
- The extra step takes time, and for simple problems the delay is not worth it.
- No plan, however carefully reviewed, can guarantee a particular result.
When to Seek Care
- Urgent problems are never delayed for a meeting. Difficulty breathing or chest pain — seek emergency care immediately.
- Severe pain, especially at an operation site, or pain that is worsening rather than settling.
- Fever with spreading redness, or a wound that is opening or failing to heal.
- A lesion that is growing rapidly or bleeding, or one that is changing noticeably.
References & Further Reading
- World Health Organization (WHO) — patient safety and integrated care resources
- National Institute for Health and Care Excellence (NICE, UK) — guidance on multidisciplinary team meetings
- American Society of Plastic Surgeons (ASPS) — reconstructive surgery and safety guidance
- Chinese Medical Association — plastic surgery and clinical practice guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.